Form 8-K - Current report:
SEC Accession No. 0001104659-21-001570
Filing Date
2021-01-06
Accepted
2021-01-06 17:00:20
Documents
13
Period of Report
2020-12-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm211488d1_8k.htm   iXBRL 8-K 46719
  Complete submission text file 0001104659-21-001570.txt   330406

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA abbv-20201231.xsd EX-101.SCH 5649
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abbv-20201231_def.xml EX-101.DEF 32379
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE abbv-20201231_lab.xml EX-101.LAB 47308
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abbv-20201231_pre.xml EX-101.PRE 30443
6 EXTRACTED XBRL INSTANCE DOCUMENT tm211488d1_8k_htm.xml XML 15668
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 21511444
SIC: 2834 Pharmaceutical Preparations